nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP3A4—Rivastigmine—Alzheimer's disease	0.126	0.432	CbGbCtD
Trametinib—CYP3A4—Donepezil—Alzheimer's disease	0.101	0.345	CbGbCtD
Trametinib—CYP3A4—Galantamine—Alzheimer's disease	0.065	0.223	CbGbCtD
Trametinib—MAP2K1—embryo—Alzheimer's disease	0.00723	0.128	CbGeAlD
Trametinib—MAP2K1—forebrain—Alzheimer's disease	0.00639	0.113	CbGeAlD
Trametinib—MAP2K1—telencephalon—Alzheimer's disease	0.00588	0.104	CbGeAlD
Trametinib—MAP2K2—forebrain—Alzheimer's disease	0.00563	0.0997	CbGeAlD
Trametinib—MAP2K2—telencephalon—Alzheimer's disease	0.00517	0.0917	CbGeAlD
Trametinib—MAP2K1—nervous system—Alzheimer's disease	0.00347	0.0615	CbGeAlD
Trametinib—MAP2K1—central nervous system—Alzheimer's disease	0.00334	0.0592	CbGeAlD
Trametinib—MAP2K1—cerebellum—Alzheimer's disease	0.00327	0.0578	CbGeAlD
Trametinib—MAP2K2—nervous system—Alzheimer's disease	0.00306	0.0541	CbGeAlD
Trametinib—MAP2K2—central nervous system—Alzheimer's disease	0.00294	0.0521	CbGeAlD
Trametinib—MAP2K2—cerebellum—Alzheimer's disease	0.00287	0.0509	CbGeAlD
Trametinib—MAP2K1—brain—Alzheimer's disease	0.00265	0.047	CbGeAlD
Trametinib—MAP2K2—brain—Alzheimer's disease	0.00234	0.0414	CbGeAlD
Trametinib—Neoplasm—Rivastigmine—Alzheimer's disease	0.00142	0.00429	CcSEcCtD
Trametinib—Cardiac failure congestive—Donepezil—Alzheimer's disease	0.00141	0.00427	CcSEcCtD
Trametinib—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00137	0.00414	CcSEcCtD
Trametinib—Blood alkaline phosphatase increased—Memantine—Alzheimer's disease	0.00134	0.00404	CcSEcCtD
Trametinib—Blood alkaline phosphatase increased—Rivastigmine—Alzheimer's disease	0.00131	0.00396	CcSEcCtD
Trametinib—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00129	0.0039	CcSEcCtD
Trametinib—Hyponatraemia—Donepezil—Alzheimer's disease	0.00129	0.00389	CcSEcCtD
Trametinib—Cardiac failure congestive—Memantine—Alzheimer's disease	0.00128	0.00388	CcSEcCtD
Trametinib—Renal failure acute—Memantine—Alzheimer's disease	0.00126	0.00381	CcSEcCtD
Trametinib—Renal failure—Galantamine—Alzheimer's disease	0.00125	0.00379	CcSEcCtD
Trametinib—Urinary tract infection—Galantamine—Alzheimer's disease	0.00124	0.00374	CcSEcCtD
Trametinib—Renal failure acute—Rivastigmine—Alzheimer's disease	0.00123	0.00373	CcSEcCtD
Trametinib—Haematuria—Galantamine—Alzheimer's disease	0.00122	0.00367	CcSEcCtD
Trametinib—Epistaxis—Galantamine—Alzheimer's disease	0.0012	0.00363	CcSEcCtD
Trametinib—Blood creatinine increased—Donepezil—Alzheimer's disease	0.0012	0.00363	CcSEcCtD
Trametinib—Dehydration—Donepezil—Alzheimer's disease	0.00119	0.0036	CcSEcCtD
Trametinib—Dry skin—Donepezil—Alzheimer's disease	0.00118	0.00355	CcSEcCtD
Trametinib—Abdominal pain upper—Donepezil—Alzheimer's disease	0.00117	0.00354	CcSEcCtD
Trametinib—Hyponatraemia—Memantine—Alzheimer's disease	0.00117	0.00353	CcSEcCtD
Trametinib—Hypokalaemia—Donepezil—Alzheimer's disease	0.00117	0.00353	CcSEcCtD
Trametinib—Bradycardia—Galantamine—Alzheimer's disease	0.00117	0.00352	CcSEcCtD
Trametinib—Pain in extremity—Memantine—Alzheimer's disease	0.00116	0.00352	CcSEcCtD
Trametinib—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.00116	0.00349	CcSEcCtD
Trametinib—Haemoglobin—Galantamine—Alzheimer's disease	0.00115	0.00348	CcSEcCtD
Trametinib—Haemorrhage—Galantamine—Alzheimer's disease	0.00115	0.00346	CcSEcCtD
Trametinib—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.00114	0.00345	CcSEcCtD
Trametinib—Pain in extremity—Rivastigmine—Alzheimer's disease	0.00114	0.00344	CcSEcCtD
Trametinib—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.00113	0.00342	CcSEcCtD
Trametinib—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00113	0.00341	CcSEcCtD
Trametinib—Oedema peripheral—Galantamine—Alzheimer's disease	0.00113	0.00341	CcSEcCtD
Trametinib—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00113	0.0034	CcSEcCtD
Trametinib—Urethral disorder—Galantamine—Alzheimer's disease	0.00112	0.00339	CcSEcCtD
Trametinib—Blood creatinine increased—Memantine—Alzheimer's disease	0.00109	0.00329	CcSEcCtD
Trametinib—Pancreatitis—Donepezil—Alzheimer's disease	0.00109	0.00328	CcSEcCtD
Trametinib—Dehydration—Memantine—Alzheimer's disease	0.00108	0.00327	CcSEcCtD
Trametinib—Eye disorder—Galantamine—Alzheimer's disease	0.00107	0.00323	CcSEcCtD
Trametinib—Dry skin—Memantine—Alzheimer's disease	0.00107	0.00322	CcSEcCtD
Trametinib—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00106	0.00321	CcSEcCtD
Trametinib—Cardiac disorder—Galantamine—Alzheimer's disease	0.00106	0.00321	CcSEcCtD
Trametinib—Hypokalaemia—Memantine—Alzheimer's disease	0.00106	0.0032	CcSEcCtD
Trametinib—Dehydration—Rivastigmine—Alzheimer's disease	0.00106	0.0032	CcSEcCtD
Trametinib—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.00105	0.00317	CcSEcCtD
Trametinib—Dry skin—Rivastigmine—Alzheimer's disease	0.00104	0.00315	CcSEcCtD
Trametinib—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.00104	0.00314	CcSEcCtD
Trametinib—Angiopathy—Galantamine—Alzheimer's disease	0.00104	0.00314	CcSEcCtD
Trametinib—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.00104	0.00313	CcSEcCtD
Trametinib—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.00103	0.0031	CcSEcCtD
Trametinib—Arrhythmia—Galantamine—Alzheimer's disease	0.00102	0.00309	CcSEcCtD
Trametinib—Mental disorder—Galantamine—Alzheimer's disease	0.001	0.00303	CcSEcCtD
Trametinib—Hyperglycaemia—Donepezil—Alzheimer's disease	0.001	0.00302	CcSEcCtD
Trametinib—Malnutrition—Galantamine—Alzheimer's disease	0.000997	0.00301	CcSEcCtD
Trametinib—Infestation—Donepezil—Alzheimer's disease	0.000989	0.00298	CcSEcCtD
Trametinib—Infestation NOS—Donepezil—Alzheimer's disease	0.000989	0.00298	CcSEcCtD
Trametinib—Pancreatitis—Memantine—Alzheimer's disease	0.000987	0.00298	CcSEcCtD
Trametinib—Dysgeusia—Galantamine—Alzheimer's disease	0.000976	0.00295	CcSEcCtD
Trametinib—Renal failure—Donepezil—Alzheimer's disease	0.000972	0.00293	CcSEcCtD
Trametinib—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000966	0.00292	CcSEcCtD
Trametinib—Back pain—Galantamine—Alzheimer's disease	0.000964	0.00291	CcSEcCtD
Trametinib—Urinary tract infection—Donepezil—Alzheimer's disease	0.000961	0.0029	CcSEcCtD
Trametinib—Muscle spasms—Galantamine—Alzheimer's disease	0.000958	0.00289	CcSEcCtD
Trametinib—Haematuria—Donepezil—Alzheimer's disease	0.000943	0.00285	CcSEcCtD
Trametinib—Neutropenia—Memantine—Alzheimer's disease	0.000941	0.00284	CcSEcCtD
Trametinib—Vision blurred—Galantamine—Alzheimer's disease	0.000939	0.00284	CcSEcCtD
Trametinib—Epistaxis—Donepezil—Alzheimer's disease	0.000932	0.00282	CcSEcCtD
Trametinib—Anaemia—Galantamine—Alzheimer's disease	0.000921	0.00278	CcSEcCtD
Trametinib—Hyperglycaemia—Memantine—Alzheimer's disease	0.000908	0.00274	CcSEcCtD
Trametinib—Bradycardia—Donepezil—Alzheimer's disease	0.000903	0.00273	CcSEcCtD
Trametinib—Infestation—Memantine—Alzheimer's disease	0.000898	0.00271	CcSEcCtD
Trametinib—Infestation NOS—Memantine—Alzheimer's disease	0.000898	0.00271	CcSEcCtD
Trametinib—Haemoglobin—Donepezil—Alzheimer's disease	0.000892	0.00269	CcSEcCtD
Trametinib—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000888	0.00268	CcSEcCtD
Trametinib—Haemorrhage—Donepezil—Alzheimer's disease	0.000887	0.00268	CcSEcCtD
Trametinib—Renal failure—Memantine—Alzheimer's disease	0.000882	0.00266	CcSEcCtD
Trametinib—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000878	0.00265	CcSEcCtD
Trametinib—Infestation—Rivastigmine—Alzheimer's disease	0.000878	0.00265	CcSEcCtD
Trametinib—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000876	0.00265	CcSEcCtD
Trametinib—Oedema peripheral—Donepezil—Alzheimer's disease	0.000874	0.00264	CcSEcCtD
Trametinib—Urinary tract infection—Memantine—Alzheimer's disease	0.000872	0.00263	CcSEcCtD
Trametinib—Urethral disorder—Donepezil—Alzheimer's disease	0.00087	0.00263	CcSEcCtD
Trametinib—Cough—Galantamine—Alzheimer's disease	0.00087	0.00263	CcSEcCtD
Trametinib—Renal failure—Rivastigmine—Alzheimer's disease	0.000863	0.00261	CcSEcCtD
Trametinib—Hypertension—Galantamine—Alzheimer's disease	0.000861	0.0026	CcSEcCtD
Trametinib—Haematuria—Memantine—Alzheimer's disease	0.000856	0.00258	CcSEcCtD
Trametinib—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000854	0.00258	CcSEcCtD
Trametinib—Myalgia—Galantamine—Alzheimer's disease	0.000849	0.00256	CcSEcCtD
Trametinib—Arthralgia—Galantamine—Alzheimer's disease	0.000849	0.00256	CcSEcCtD
Trametinib—Epistaxis—Memantine—Alzheimer's disease	0.000847	0.00256	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000843	0.00254	CcSEcCtD
Trametinib—Haematuria—Rivastigmine—Alzheimer's disease	0.000837	0.00253	CcSEcCtD
Trametinib—Dry mouth—Galantamine—Alzheimer's disease	0.00083	0.00251	CcSEcCtD
Trametinib—Epistaxis—Rivastigmine—Alzheimer's disease	0.000828	0.0025	CcSEcCtD
Trametinib—Bradycardia—Memantine—Alzheimer's disease	0.00082	0.00248	CcSEcCtD
Trametinib—Haemoglobin—Memantine—Alzheimer's disease	0.00081	0.00245	CcSEcCtD
Trametinib—CYP2C8—brain—Alzheimer's disease	0.000809	0.0143	CbGeAlD
Trametinib—Haemorrhage—Memantine—Alzheimer's disease	0.000806	0.00243	CcSEcCtD
Trametinib—Bradycardia—Rivastigmine—Alzheimer's disease	0.000802	0.00242	CcSEcCtD
Trametinib—Nervous system disorder—Galantamine—Alzheimer's disease	0.000798	0.00241	CcSEcCtD
Trametinib—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000797	0.00241	CcSEcCtD
Trametinib—Chills—Donepezil—Alzheimer's disease	0.000796	0.0024	CcSEcCtD
Trametinib—Urinary tract disorder—Memantine—Alzheimer's disease	0.000796	0.0024	CcSEcCtD
Trametinib—Oedema peripheral—Memantine—Alzheimer's disease	0.000794	0.0024	CcSEcCtD
Trametinib—Arrhythmia—Donepezil—Alzheimer's disease	0.000793	0.00239	CcSEcCtD
Trametinib—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000792	0.00239	CcSEcCtD
Trametinib—Connective tissue disorder—Memantine—Alzheimer's disease	0.000792	0.00239	CcSEcCtD
Trametinib—Skin disorder—Galantamine—Alzheimer's disease	0.00079	0.00239	CcSEcCtD
Trametinib—Urethral disorder—Memantine—Alzheimer's disease	0.00079	0.00238	CcSEcCtD
Trametinib—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000788	0.00238	CcSEcCtD
Trametinib—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000786	0.00237	CcSEcCtD
Trametinib—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000778	0.00235	CcSEcCtD
Trametinib—Mental disorder—Donepezil—Alzheimer's disease	0.000777	0.00235	CcSEcCtD
Trametinib—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000777	0.00234	CcSEcCtD
Trametinib—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000775	0.00234	CcSEcCtD
Trametinib—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000773	0.00233	CcSEcCtD
Trametinib—Erythema—Donepezil—Alzheimer's disease	0.000773	0.00233	CcSEcCtD
Trametinib—Malnutrition—Donepezil—Alzheimer's disease	0.000773	0.00233	CcSEcCtD
Trametinib—Dysgeusia—Donepezil—Alzheimer's disease	0.000757	0.00228	CcSEcCtD
Trametinib—Eye disorder—Memantine—Alzheimer's disease	0.000753	0.00227	CcSEcCtD
Trametinib—Cardiac disorder—Memantine—Alzheimer's disease	0.000748	0.00226	CcSEcCtD
Trametinib—Back pain—Donepezil—Alzheimer's disease	0.000747	0.00226	CcSEcCtD
Trametinib—Muscle spasms—Donepezil—Alzheimer's disease	0.000743	0.00224	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000741	0.00224	CcSEcCtD
Trametinib—Eye disorder—Rivastigmine—Alzheimer's disease	0.000737	0.00222	CcSEcCtD
Trametinib—Insomnia—Galantamine—Alzheimer's disease	0.000736	0.00222	CcSEcCtD
Trametinib—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000732	0.00221	CcSEcCtD
Trametinib—Angiopathy—Memantine—Alzheimer's disease	0.000731	0.00221	CcSEcCtD
Trametinib—Vision blurred—Donepezil—Alzheimer's disease	0.000728	0.0022	CcSEcCtD
Trametinib—Mediastinal disorder—Memantine—Alzheimer's disease	0.000726	0.00219	CcSEcCtD
Trametinib—Chills—Memantine—Alzheimer's disease	0.000723	0.00218	CcSEcCtD
Trametinib—Arrhythmia—Memantine—Alzheimer's disease	0.00072	0.00217	CcSEcCtD
Trametinib—CYP3A4—nervous system—Alzheimer's disease	0.000717	0.0127	CbGeAlD
Trametinib—Angiopathy—Rivastigmine—Alzheimer's disease	0.000715	0.00216	CcSEcCtD
Trametinib—Anaemia—Donepezil—Alzheimer's disease	0.000714	0.00216	CcSEcCtD
Trametinib—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00071	0.00215	CcSEcCtD
Trametinib—Chills—Rivastigmine—Alzheimer's disease	0.000707	0.00214	CcSEcCtD
Trametinib—Decreased appetite—Galantamine—Alzheimer's disease	0.000707	0.00214	CcSEcCtD
Trametinib—Mental disorder—Memantine—Alzheimer's disease	0.000706	0.00213	CcSEcCtD
Trametinib—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000704	0.00213	CcSEcCtD
Trametinib—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000702	0.00212	CcSEcCtD
Trametinib—Malnutrition—Memantine—Alzheimer's disease	0.000701	0.00212	CcSEcCtD
Trametinib—Fatigue—Galantamine—Alzheimer's disease	0.000701	0.00212	CcSEcCtD
Trametinib—Constipation—Galantamine—Alzheimer's disease	0.000696	0.0021	CcSEcCtD
Trametinib—Mental disorder—Rivastigmine—Alzheimer's disease	0.000691	0.00209	CcSEcCtD
Trametinib—CYP3A4—central nervous system—Alzheimer's disease	0.00069	0.0122	CbGeAlD
Trametinib—Dysgeusia—Memantine—Alzheimer's disease	0.000687	0.00207	CcSEcCtD
Trametinib—Malnutrition—Rivastigmine—Alzheimer's disease	0.000686	0.00207	CcSEcCtD
Trametinib—Erythema—Rivastigmine—Alzheimer's disease	0.000686	0.00207	CcSEcCtD
Trametinib—Back pain—Memantine—Alzheimer's disease	0.000678	0.00205	CcSEcCtD
Trametinib—Cough—Donepezil—Alzheimer's disease	0.000674	0.00204	CcSEcCtD
Trametinib—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000672	0.00203	CcSEcCtD
Trametinib—Hypertension—Donepezil—Alzheimer's disease	0.000667	0.00201	CcSEcCtD
Trametinib—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000665	0.00201	CcSEcCtD
Trametinib—Back pain—Rivastigmine—Alzheimer's disease	0.000664	0.002	CcSEcCtD
Trametinib—Vision blurred—Memantine—Alzheimer's disease	0.000661	0.002	CcSEcCtD
Trametinib—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00066	0.00199	CcSEcCtD
Trametinib—Myalgia—Donepezil—Alzheimer's disease	0.000658	0.00199	CcSEcCtD
Trametinib—Arthralgia—Donepezil—Alzheimer's disease	0.000658	0.00199	CcSEcCtD
Trametinib—Anaemia—Memantine—Alzheimer's disease	0.000648	0.00196	CcSEcCtD
Trametinib—Vision blurred—Rivastigmine—Alzheimer's disease	0.000647	0.00195	CcSEcCtD
Trametinib—Dry mouth—Donepezil—Alzheimer's disease	0.000643	0.00194	CcSEcCtD
Trametinib—Body temperature increased—Galantamine—Alzheimer's disease	0.000643	0.00194	CcSEcCtD
Trametinib—Abdominal pain—Galantamine—Alzheimer's disease	0.000643	0.00194	CcSEcCtD
Trametinib—Anaemia—Rivastigmine—Alzheimer's disease	0.000634	0.00192	CcSEcCtD
Trametinib—Oedema—Donepezil—Alzheimer's disease	0.00063	0.0019	CcSEcCtD
Trametinib—Leukopenia—Memantine—Alzheimer's disease	0.000628	0.0019	CcSEcCtD
Trametinib—Infection—Donepezil—Alzheimer's disease	0.000626	0.00189	CcSEcCtD
Trametinib—Nervous system disorder—Donepezil—Alzheimer's disease	0.000618	0.00187	CcSEcCtD
Trametinib—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000617	0.00186	CcSEcCtD
Trametinib—Cough—Memantine—Alzheimer's disease	0.000612	0.00185	CcSEcCtD
Trametinib—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000609	0.00184	CcSEcCtD
Trametinib—Hypertension—Memantine—Alzheimer's disease	0.000606	0.00183	CcSEcCtD
Trametinib—Cough—Rivastigmine—Alzheimer's disease	0.000599	0.00181	CcSEcCtD
Trametinib—Arthralgia—Memantine—Alzheimer's disease	0.000597	0.0018	CcSEcCtD
Trametinib—Myalgia—Memantine—Alzheimer's disease	0.000597	0.0018	CcSEcCtD
Trametinib—Hypertension—Rivastigmine—Alzheimer's disease	0.000592	0.00179	CcSEcCtD
Trametinib—Arthralgia—Rivastigmine—Alzheimer's disease	0.000584	0.00176	CcSEcCtD
Trametinib—Myalgia—Rivastigmine—Alzheimer's disease	0.000584	0.00176	CcSEcCtD
Trametinib—Dry mouth—Memantine—Alzheimer's disease	0.000584	0.00176	CcSEcCtD
Trametinib—Asthenia—Galantamine—Alzheimer's disease	0.000584	0.00176	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00058	0.00175	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000574	0.00173	CcSEcCtD
Trametinib—Oedema—Memantine—Alzheimer's disease	0.000572	0.00173	CcSEcCtD
Trametinib—Dry mouth—Rivastigmine—Alzheimer's disease	0.000571	0.00173	CcSEcCtD
Trametinib—Insomnia—Donepezil—Alzheimer's disease	0.00057	0.00172	CcSEcCtD
Trametinib—Infection—Memantine—Alzheimer's disease	0.000569	0.00172	CcSEcCtD
Trametinib—Nervous system disorder—Memantine—Alzheimer's disease	0.000561	0.0017	CcSEcCtD
Trametinib—Thrombocytopenia—Memantine—Alzheimer's disease	0.00056	0.00169	CcSEcCtD
Trametinib—Oedema—Rivastigmine—Alzheimer's disease	0.00056	0.00169	CcSEcCtD
Trametinib—Diarrhoea—Galantamine—Alzheimer's disease	0.000557	0.00168	CcSEcCtD
Trametinib—Infection—Rivastigmine—Alzheimer's disease	0.000556	0.00168	CcSEcCtD
Trametinib—Skin disorder—Memantine—Alzheimer's disease	0.000556	0.00168	CcSEcCtD
Trametinib—Hyperhidrosis—Memantine—Alzheimer's disease	0.000553	0.00167	CcSEcCtD
Trametinib—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000549	0.00166	CcSEcCtD
Trametinib—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000548	0.00166	CcSEcCtD
Trametinib—Decreased appetite—Donepezil—Alzheimer's disease	0.000548	0.00165	CcSEcCtD
Trametinib—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000544	0.00164	CcSEcCtD
Trametinib—Skin disorder—Rivastigmine—Alzheimer's disease	0.000544	0.00164	CcSEcCtD
Trametinib—Fatigue—Donepezil—Alzheimer's disease	0.000544	0.00164	CcSEcCtD
Trametinib—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000541	0.00163	CcSEcCtD
Trametinib—Constipation—Donepezil—Alzheimer's disease	0.000539	0.00163	CcSEcCtD
Trametinib—Dizziness—Galantamine—Alzheimer's disease	0.000538	0.00162	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000522	0.00157	CcSEcCtD
Trametinib—Insomnia—Memantine—Alzheimer's disease	0.000518	0.00156	CcSEcCtD
Trametinib—Vomiting—Galantamine—Alzheimer's disease	0.000517	0.00156	CcSEcCtD
Trametinib—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000516	0.00156	CcSEcCtD
Trametinib—Rash—Galantamine—Alzheimer's disease	0.000513	0.00155	CcSEcCtD
Trametinib—Dermatitis—Galantamine—Alzheimer's disease	0.000512	0.00155	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00051	0.00154	CcSEcCtD
Trametinib—Headache—Galantamine—Alzheimer's disease	0.00051	0.00154	CcSEcCtD
Trametinib—Insomnia—Rivastigmine—Alzheimer's disease	0.000507	0.00153	CcSEcCtD
Trametinib—Body temperature increased—Donepezil—Alzheimer's disease	0.000498	0.0015	CcSEcCtD
Trametinib—Abdominal pain—Donepezil—Alzheimer's disease	0.000498	0.0015	CcSEcCtD
Trametinib—Decreased appetite—Memantine—Alzheimer's disease	0.000498	0.0015	CcSEcCtD
Trametinib—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000494	0.00149	CcSEcCtD
Trametinib—Fatigue—Memantine—Alzheimer's disease	0.000494	0.00149	CcSEcCtD
Trametinib—Constipation—Memantine—Alzheimer's disease	0.00049	0.00148	CcSEcCtD
Trametinib—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000487	0.00147	CcSEcCtD
Trametinib—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000483	0.00146	CcSEcCtD
Trametinib—Nausea—Galantamine—Alzheimer's disease	0.000483	0.00146	CcSEcCtD
Trametinib—Fatigue—Rivastigmine—Alzheimer's disease	0.000483	0.00146	CcSEcCtD
Trametinib—Constipation—Rivastigmine—Alzheimer's disease	0.000479	0.00145	CcSEcCtD
Trametinib—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000468	0.00141	CcSEcCtD
Trametinib—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000458	0.00138	CcSEcCtD
Trametinib—Abdominal pain—Memantine—Alzheimer's disease	0.000453	0.00137	CcSEcCtD
Trametinib—Body temperature increased—Memantine—Alzheimer's disease	0.000453	0.00137	CcSEcCtD
Trametinib—Asthenia—Donepezil—Alzheimer's disease	0.000452	0.00137	CcSEcCtD
Trametinib—Pruritus—Donepezil—Alzheimer's disease	0.000446	0.00135	CcSEcCtD
Trametinib—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000443	0.00134	CcSEcCtD
Trametinib—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000443	0.00134	CcSEcCtD
Trametinib—Diarrhoea—Donepezil—Alzheimer's disease	0.000431	0.0013	CcSEcCtD
Trametinib—Dizziness—Donepezil—Alzheimer's disease	0.000417	0.00126	CcSEcCtD
Trametinib—Asthenia—Memantine—Alzheimer's disease	0.000411	0.00124	CcSEcCtD
Trametinib—Pruritus—Memantine—Alzheimer's disease	0.000405	0.00122	CcSEcCtD
Trametinib—Asthenia—Rivastigmine—Alzheimer's disease	0.000402	0.00121	CcSEcCtD
Trametinib—Vomiting—Donepezil—Alzheimer's disease	0.000401	0.00121	CcSEcCtD
Trametinib—Rash—Donepezil—Alzheimer's disease	0.000398	0.0012	CcSEcCtD
Trametinib—Dermatitis—Donepezil—Alzheimer's disease	0.000397	0.0012	CcSEcCtD
Trametinib—Pruritus—Rivastigmine—Alzheimer's disease	0.000396	0.0012	CcSEcCtD
Trametinib—Headache—Donepezil—Alzheimer's disease	0.000395	0.00119	CcSEcCtD
Trametinib—Diarrhoea—Memantine—Alzheimer's disease	0.000392	0.00118	CcSEcCtD
Trametinib—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000383	0.00116	CcSEcCtD
Trametinib—Dizziness—Memantine—Alzheimer's disease	0.000379	0.00114	CcSEcCtD
Trametinib—Nausea—Donepezil—Alzheimer's disease	0.000374	0.00113	CcSEcCtD
Trametinib—Dizziness—Rivastigmine—Alzheimer's disease	0.00037	0.00112	CcSEcCtD
Trametinib—Vomiting—Memantine—Alzheimer's disease	0.000364	0.0011	CcSEcCtD
Trametinib—Rash—Memantine—Alzheimer's disease	0.000361	0.00109	CcSEcCtD
Trametinib—Dermatitis—Memantine—Alzheimer's disease	0.000361	0.00109	CcSEcCtD
Trametinib—Headache—Memantine—Alzheimer's disease	0.000359	0.00108	CcSEcCtD
Trametinib—Vomiting—Rivastigmine—Alzheimer's disease	0.000356	0.00108	CcSEcCtD
Trametinib—Rash—Rivastigmine—Alzheimer's disease	0.000353	0.00107	CcSEcCtD
Trametinib—Dermatitis—Rivastigmine—Alzheimer's disease	0.000353	0.00107	CcSEcCtD
Trametinib—Headache—Rivastigmine—Alzheimer's disease	0.000351	0.00106	CcSEcCtD
Trametinib—Nausea—Memantine—Alzheimer's disease	0.00034	0.00103	CcSEcCtD
Trametinib—Nausea—Rivastigmine—Alzheimer's disease	0.000333	0.001	CcSEcCtD
Trametinib—MAP2K2—Innate Immune System—BCL2—Alzheimer's disease	3.31e-05	0.000103	CbGpPWpGaD
Trametinib—MAP2K1—Disease—ADAM10—Alzheimer's disease	3.3e-05	0.000103	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL1A—Alzheimer's disease	3.27e-05	0.000102	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CRH—Alzheimer's disease	3.26e-05	0.000102	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CCR5—Alzheimer's disease	3.22e-05	0.0001	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PRKCG—Alzheimer's disease	3.18e-05	9.92e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NPY—Alzheimer's disease	3.16e-05	9.87e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—MEF2C—Alzheimer's disease	3.16e-05	9.87e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HTR2A—Alzheimer's disease	3.15e-05	9.83e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IAPP—Alzheimer's disease	3.14e-05	9.81e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—AGER—Alzheimer's disease	3.14e-05	9.78e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PRKCG—Alzheimer's disease	3.1e-05	9.68e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—BCL2—Alzheimer's disease	3.1e-05	9.67e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	3.1e-05	9.67e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NPS—Alzheimer's disease	3.09e-05	9.65e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PPP3CA—Alzheimer's disease	3.08e-05	9.6e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL1A—Alzheimer's disease	3.06e-05	9.55e-05	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL6—Alzheimer's disease	3.06e-05	9.54e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CRH—Alzheimer's disease	3.05e-05	9.52e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PTK2B—Alzheimer's disease	3.03e-05	9.46e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CCR5—Alzheimer's disease	3.01e-05	9.4e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—IL6—Alzheimer's disease	3.01e-05	9.38e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MEF2C—Alzheimer's disease	2.96e-05	9.23e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GAB2—Alzheimer's disease	2.95e-05	9.21e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SST—Alzheimer's disease	2.95e-05	9.21e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NTRK2—Alzheimer's disease	2.95e-05	9.21e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—LPL—Alzheimer's disease	2.95e-05	9.19e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HTR2A—Alzheimer's disease	2.95e-05	9.19e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CALM1—Alzheimer's disease	2.94e-05	9.17e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—AGER—Alzheimer's disease	2.93e-05	9.15e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GSK3A—Alzheimer's disease	2.92e-05	9.13e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PRKCG—Alzheimer's disease	2.9e-05	9.06e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NPS—Alzheimer's disease	2.89e-05	9.03e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PPP3CA—Alzheimer's disease	2.88e-05	8.98e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APP—Alzheimer's disease	2.88e-05	8.97e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.87e-05	8.94e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PRKCG—Alzheimer's disease	2.87e-05	8.94e-05	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL6—Alzheimer's disease	2.86e-05	8.93e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PTK2B—Alzheimer's disease	2.84e-05	8.85e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—IL6—Alzheimer's disease	2.81e-05	8.78e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—VEGFA—Alzheimer's disease	2.81e-05	8.76e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—AKT1—Alzheimer's disease	2.77e-05	8.65e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—F2—Alzheimer's disease	2.76e-05	8.62e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NTRK2—Alzheimer's disease	2.76e-05	8.61e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GAB2—Alzheimer's disease	2.76e-05	8.61e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SST—Alzheimer's disease	2.76e-05	8.61e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—LPL—Alzheimer's disease	2.76e-05	8.6e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CALM1—Alzheimer's disease	2.75e-05	8.58e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GSK3A—Alzheimer's disease	2.74e-05	8.54e-05	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—IL6—Alzheimer's disease	2.72e-05	8.49e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CCR5—Alzheimer's disease	2.71e-05	8.47e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PLCB1—Alzheimer's disease	2.71e-05	8.47e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APP—Alzheimer's disease	2.69e-05	8.39e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—MAPK8—Alzheimer's disease	2.69e-05	8.38e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CALM1—Alzheimer's disease	2.68e-05	8.38e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PRKCG—Alzheimer's disease	2.68e-05	8.36e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MTHFR—Alzheimer's disease	2.65e-05	8.28e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.63e-05	8.22e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—VEGFA—Alzheimer's disease	2.63e-05	8.19e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.61e-05	8.14e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—AKT1—Alzheimer's disease	2.59e-05	8.1e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—F2—Alzheimer's disease	2.58e-05	8.06e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TGFB1—Alzheimer's disease	2.58e-05	8.04e-05	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—IL6—Alzheimer's disease	2.55e-05	7.94e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CCR5—Alzheimer's disease	2.54e-05	7.93e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PLCB1—Alzheimer's disease	2.54e-05	7.92e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NGFR—Alzheimer's disease	2.53e-05	7.9e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CREB1—Alzheimer's disease	2.52e-05	7.85e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—MAPK8—Alzheimer's disease	2.51e-05	7.84e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CALM1—Alzheimer's disease	2.51e-05	7.84e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MTHFR—Alzheimer's disease	2.48e-05	7.75e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CALM1—Alzheimer's disease	2.48e-05	7.73e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.48e-05	7.73e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ADAM10—Alzheimer's disease	2.47e-05	7.71e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—APOE—Alzheimer's disease	2.47e-05	7.71e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CCL2—Alzheimer's disease	2.46e-05	7.68e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CAV1—Alzheimer's disease	2.45e-05	7.64e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TGFB1—Alzheimer's disease	2.41e-05	7.52e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TNF—Alzheimer's disease	2.41e-05	7.51e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CHAT—Alzheimer's disease	2.4e-05	7.48e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—TPI1—Alzheimer's disease	2.4e-05	7.48e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NGFR—Alzheimer's disease	2.37e-05	7.39e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CREB1—Alzheimer's disease	2.35e-05	7.34e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.35e-05	7.33e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—S100B—Alzheimer's disease	2.34e-05	7.3e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CALM1—Alzheimer's disease	2.32e-05	7.24e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—GSK3B—Alzheimer's disease	2.32e-05	7.23e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ADAM10—Alzheimer's disease	2.31e-05	7.22e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—APOE—Alzheimer's disease	2.31e-05	7.21e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CCL2—Alzheimer's disease	2.3e-05	7.18e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS2—Alzheimer's disease	2.3e-05	7.18e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CREB1—Alzheimer's disease	2.3e-05	7.17e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MAOB—Alzheimer's disease	2.3e-05	7.17e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CAV1—Alzheimer's disease	2.29e-05	7.14e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOTCH1—Alzheimer's disease	2.28e-05	7.11e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TNF—Alzheimer's disease	2.25e-05	7.02e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.24e-05	6.99e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IGF2—Alzheimer's disease	2.23e-05	6.95e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	2.21e-05	6.9e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—S100B—Alzheimer's disease	2.19e-05	6.83e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.19e-05	6.82e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—GSK3B—Alzheimer's disease	2.17e-05	6.76e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.17e-05	6.76e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS2—Alzheimer's disease	2.15e-05	6.72e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IGF1R—Alzheimer's disease	2.15e-05	6.72e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CREB1—Alzheimer's disease	2.15e-05	6.71e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	2.15e-05	6.7e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—GSK3B—Alzheimer's disease	2.14e-05	6.67e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—A2M—Alzheimer's disease	2.14e-05	6.67e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOTCH1—Alzheimer's disease	2.13e-05	6.65e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CREB1—Alzheimer's disease	2.12e-05	6.62e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—INS—Alzheimer's disease	2.11e-05	6.58e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF2—Alzheimer's disease	2.08e-05	6.5e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	2.07e-05	6.45e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—LPL—Alzheimer's disease	2.06e-05	6.44e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MEF2C—Alzheimer's disease	2.04e-05	6.38e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF1R—Alzheimer's disease	2.01e-05	6.28e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PRKCG—Alzheimer's disease	2.01e-05	6.26e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—GSK3B—Alzheimer's disease	2e-05	6.24e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ND1—Alzheimer's disease	2e-05	6.23e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CREB1—Alzheimer's disease	1.99e-05	6.19e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—INS—Alzheimer's disease	1.97e-05	6.16e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NGF—Alzheimer's disease	1.95e-05	6.1e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—IL6—Alzheimer's disease	1.94e-05	6.06e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—LPL—Alzheimer's disease	1.93e-05	6.02e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—BCL2—Alzheimer's disease	1.93e-05	6.02e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MEF2C—Alzheimer's disease	1.91e-05	5.97e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.9e-05	5.94e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCR5—Alzheimer's disease	1.9e-05	5.93e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PRKCG—Alzheimer's disease	1.88e-05	5.86e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR2A—Alzheimer's disease	1.86e-05	5.81e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ACHE—Alzheimer's disease	1.86e-05	5.8e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS3—Alzheimer's disease	1.85e-05	5.77e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	1.84e-05	5.73e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NGF—Alzheimer's disease	1.83e-05	5.71e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—IL6—Alzheimer's disease	1.82e-05	5.67e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—BCL2—Alzheimer's disease	1.81e-05	5.63e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—AKT1—Alzheimer's disease	1.79e-05	5.59e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCR5—Alzheimer's disease	1.78e-05	5.55e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	1.74e-05	5.43e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ENO1—Alzheimer's disease	1.74e-05	5.43e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR2A—Alzheimer's disease	1.74e-05	5.43e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CALM1—Alzheimer's disease	1.74e-05	5.42e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS3—Alzheimer's disease	1.73e-05	5.4e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—LEP—Alzheimer's disease	1.73e-05	5.4e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOE—Alzheimer's disease	1.73e-05	5.4e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IL6—Alzheimer's disease	1.71e-05	5.35e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CAV1—Alzheimer's disease	1.71e-05	5.35e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	1.71e-05	5.33e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL1B—Alzheimer's disease	1.71e-05	5.32e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTGS2—Alzheimer's disease	1.69e-05	5.28e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—AKT1—Alzheimer's disease	1.68e-05	5.23e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ESR1—Alzheimer's disease	1.65e-05	5.15e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—F2—Alzheimer's disease	1.63e-05	5.09e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CALM1—Alzheimer's disease	1.62e-05	5.07e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—BCHE—Alzheimer's disease	1.62e-05	5.05e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOE—Alzheimer's disease	1.62e-05	5.05e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—LEP—Alzheimer's disease	1.62e-05	5.05e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IL6—Alzheimer's disease	1.6e-05	5.01e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CAV1—Alzheimer's disease	1.6e-05	5e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOTCH1—Alzheimer's disease	1.6e-05	4.98e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL1B—Alzheimer's disease	1.6e-05	4.98e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTGS2—Alzheimer's disease	1.58e-05	4.94e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—AKT1—Alzheimer's disease	1.58e-05	4.94e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—MAPK8—Alzheimer's disease	1.56e-05	4.88e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ESR1—Alzheimer's disease	1.54e-05	4.82e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	1.53e-05	4.77e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—F2—Alzheimer's disease	1.53e-05	4.76e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.5e-05	4.68e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GSK3B—Alzheimer's disease	1.5e-05	4.67e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.49e-05	4.66e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CREB1—Alzheimer's disease	1.49e-05	4.64e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	1.48e-05	4.62e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—AKT1—Alzheimer's disease	1.48e-05	4.62e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—INS—Alzheimer's disease	1.48e-05	4.61e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MAPK8—Alzheimer's disease	1.46e-05	4.57e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL2—Alzheimer's disease	1.45e-05	4.54e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IGF1—Alzheimer's disease	1.43e-05	4.46e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GSK3B—Alzheimer's disease	1.4e-05	4.37e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CREB1—Alzheimer's disease	1.39e-05	4.34e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—INS—Alzheimer's disease	1.38e-05	4.31e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL2—Alzheimer's disease	1.36e-05	4.24e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF1—Alzheimer's disease	1.34e-05	4.17e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOS3—Alzheimer's disease	1.3e-05	4.04e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.29e-05	4.01e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.29e-05	4.01e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	1.28e-05	3.98e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	1.27e-05	3.96e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.23e-05	3.85e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TGFB1—Alzheimer's disease	1.22e-05	3.82e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOS3—Alzheimer's disease	1.21e-05	3.78e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.19e-05	3.7e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—LPL—Alzheimer's disease	1.16e-05	3.63e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.15e-05	3.58e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TGFB1—Alzheimer's disease	1.14e-05	3.57e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CASP3—Alzheimer's disease	1.1e-05	3.43e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL6—Alzheimer's disease	1.09e-05	3.41e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	1.05e-05	3.26e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CASP3—Alzheimer's disease	1.03e-05	3.21e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6—Alzheimer's disease	1.02e-05	3.19e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MAPK8—Alzheimer's disease	1.01e-05	3.15e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—AKT1—Alzheimer's disease	1.01e-05	3.15e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6—Alzheimer's disease	9.99e-06	3.12e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ACHE—Alzheimer's disease	9.97e-06	3.11e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	9.86e-06	3.08e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CALM1—Alzheimer's disease	9.77e-06	3.05e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOE—Alzheimer's disease	9.74e-06	3.04e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CAV1—Alzheimer's disease	9.65e-06	3.01e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MAPK8—Alzheimer's disease	9.46e-06	2.95e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—AKT1—Alzheimer's disease	9.43e-06	2.94e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ENO1—Alzheimer's disease	9.35e-06	2.92e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	9.35e-06	2.92e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6—Alzheimer's disease	9.34e-06	2.92e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—VEGFA—Alzheimer's disease	9.34e-06	2.91e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6—Alzheimer's disease	9.22e-06	2.88e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—AKT1—Alzheimer's disease	9.21e-06	2.87e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	9.17e-06	2.86e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—VEGFA—Alzheimer's disease	8.73e-06	2.73e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—BCHE—Alzheimer's disease	8.69e-06	2.71e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6—Alzheimer's disease	8.63e-06	2.69e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—AKT1—Alzheimer's disease	8.62e-06	2.69e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TGFB1—Alzheimer's disease	8.57e-06	2.67e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—AKT1—Alzheimer's disease	8.51e-06	2.65e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARG—Alzheimer's disease	8.48e-06	2.65e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—INS—Alzheimer's disease	8.32e-06	2.6e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	8.2e-06	2.56e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TGFB1—Alzheimer's disease	8.02e-06	2.5e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—AKT1—Alzheimer's disease	7.96e-06	2.48e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	7.95e-06	2.48e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NOS3—Alzheimer's disease	7.3e-06	2.28e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TP53—Alzheimer's disease	7.05e-06	2.2e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	6.85e-06	2.14e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	6.82e-06	2.13e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	6.67e-06	2.08e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TP53—Alzheimer's disease	6.6e-06	2.06e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6—Alzheimer's disease	6.46e-06	2.01e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LPL—Alzheimer's disease	6.24e-06	1.95e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6—Alzheimer's disease	6.04e-06	1.88e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AKT1—Alzheimer's disease	5.96e-06	1.86e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	5.61e-06	1.75e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AKT1—Alzheimer's disease	5.57e-06	1.74e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CALM1—Alzheimer's disease	5.25e-06	1.64e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOE—Alzheimer's disease	5.23e-06	1.63e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CAV1—Alzheimer's disease	5.18e-06	1.62e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARG—Alzheimer's disease	4.55e-06	1.42e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—INS—Alzheimer's disease	4.47e-06	1.39e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.92e-06	1.22e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	3.58e-06	1.12e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AKT1—Alzheimer's disease	3.35e-06	1.05e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.8e-06	5.62e-06	CbGpPWpGaD
